Holen Sie sich die Stockscreener-App
50.36
2.06%
1.57
Schlusskurs vom Vortag:
$48.79
Offen:
$49.76
24-Stunden-Volumen:
87,690
Relative Volume:
0.21
Marktkapitalisierung:
$3.59B
Einnahmen:
$751.00K
Nettoeinkommen (Verlust:
$-74.57M
KGV:
-45.65
EPS:
-1.1031
Netto-Cashflow:
$-55.52M
1W Leistung:
-5.48%
1M Leistung:
+17.41%
6M Leistung:
+172.77%
1J Leistung:
+233.30%
1-Tages-Spanne:
$48.43
$50.57
1-Wochen-Bereich:
$47.70
$55.37
52-Wochen-Spanne:
$12.56
$55.37
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
50.35 | 3.48B | 751.00K | -74.57M | -55.52M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
353.20 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.17 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.04 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.25 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.76 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Canada
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Stock Price Forecast. Should You Buy PLSE? - StockInvest.us
Pulse Biosciences stock holds steady as investors eye recent clinical and financial progress - AD HOC NEWS
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Pulse Biosciences Inc (DE) (PLSE) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com India
COO pays nearly $50 a share for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
$Pulse Biosciences (PLSE.US)$ New ATH 🔥 - Moomoo
Pulse Biosciences Reports Teplitsky Liane Rae as New Insider COO - Kalkine Media
Pulse Biosciences stock hits new high as insider buying fuels rally - AD HOC NEWS
Pulse Biosciences stock hits all-time high at 51.0 USD - Investing.com
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Canada
Pulse Biosciences (PLSE) Slips 2% as Shares Approach Key Support at $45.19IV Crush Alert - vinanet.vn
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock By Investing.com - Investing.com Nigeria
Pulse Biosciences (NASDAQ: PLSE) links CFO options to value and revenue goals - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock - Investing.com
Pulse Biosciences (PLSE), Why Is Attention Building Around It? - Sahm
Total assets of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Operating cash flow per share of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Free cash flow per share of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Pulse Biosciences stock hits all-time high at 48.92 USD - Investing.com
$Pulse Biosciences (PLSE.US)$ shorties getting squeezed - Moomoo
Pulse (PLSE) Results Review: EPS Clears the Reported Estimate; Trading Move: Shares Rise 2.22% in the Latest ReadingDividend Growth Analysis - Vinanet
Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE - MarketBeat
Pulse Biosciences (PLSE) Launched A $75 Million Offering, Is The Upside Already Priced In? - Sahm
Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighHere's Why - MarketBeat
Pulse (PLSE) Earnings Review: EPS Exceeds Its Estimate in the Current Update; Reaction Snapshot - vinanet.vn
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga
Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Needham & Company LLC Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - MarketBeat
PLSE Initiates Coverage On by Needham -- Price Target Announced at $58.00 - GuruFocus
Needham initiates Pulse Biosciences stock with buy on ablation tech By Investing.com - Investing.com Canada
Needham Initiates Pulse Biosciences at Buy With $58 Price Target - marketscreener.com
Pulse Biosciences (PLSE) Is Up 5.0% After Wider Losses And $75M ATM Plan Filed – Has The Bull Case Changed? - simplywall.st
PULSE BIOSCIENCES INC : NEEDHAM INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $58 - Bitget
Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns - Yahoo Finance
Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform - marketbeat.com
(PLSE) Risk Channels and Responsive Allocation - Stock Traders Daily
Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued? - Yahoo Finance
PLSE Virtual Meeting on Strategic Initiatives Highlights Growth Expectations Despite High Valuation - GuruFocus
Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript - AOL.ca
Pulse Biosciences stock reaches all-time high at 46.03 USD By Investing.com - Investing.com Australia
Pulse Biosciences stock reaches all-time high at 46.03 USD - Investing.com
$Pulse Biosciences (PLSE.US)$ SQUEEZING THE SHORTIES - Moomoo
Pulse Biosciences at Canaccord Genuity conference: nsPFA push gains pace By Investing.com - Investing.com Canada
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pulse Biosciences Inc-Aktie (PLSE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 31 '26 |
Buy |
48.80 |
1,024 |
49,971 |
3,094 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 28 '26 |
Buy |
48.35 |
1,034 |
49,994 |
2,070 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 26 '26 |
Buy |
48.23 |
1,036 |
49,971 |
1,036 |
| LAVIOLETTE PAUL A | Chief Executive Officer |
May 11 '26 |
Buy |
19.69 |
15,000 |
295,350 |
15,000 |
| DUGGAN ROBERT W | Director |
May 11 '26 |
Buy |
19.69 |
660,233 |
12,999,988 |
48,211,433 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Option Exercise |
1.53 |
5,000 |
7,650 |
48,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Sale |
23.64 |
5,000 |
118,200 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 12 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 13 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 17 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
1.12%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):